What type of study is this?

This is a Literature Review study.

Research Progress on Anthracycline-Induced Cardiotoxicity in Breast Cancer Patients

View Full Paper

Ask AI

Bookmark

Authors

This review highlights cardiotoxicity risks of anthracyclines in breast cancer, suggesting strategies for monitoring and management.

Doxorubicin and other anthracyclines severely affect myocardial function in breast cancer patients.
Recent findings indicate a risk of doxorubicin-induced cardiomyopathy, reducing left ventricular ejection fraction.
Research includes classification and pathogenesis of cardiotoxicity, along with current prevention strategies.
Implications for early clinical monitoring and management are critical for patient care post-therapy.

Li et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark